Introgen Therapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Introgen Therapeutics

INGN 6.865

+4.2%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (627)	2/15/2007 3:28:45 AM
From: DewDiligence_on_SI	Read Replies (2) of 802

He said that what Introgen did was misleading and wrong Indeed it was—it was the kind of behavior one typically sees from a scam company. It seems that what is misleading and wrong is the example of "data-mining" he gives of "drug X" with left handed patients , which has no possible correlation whatsoever and is just a baseless and sneering comparison. The left-handed stuff was a way of stripping data mining to its bare essentials so that anyone could understand the concept. He doesn't mention that the European Medicines Evaluation Agency has granted the Orphan Medicinal Product Designation in Europe for the treatment of Li-Fraumeni SyndromFS using ADVEXIN That and $1.75 will get you a cup of coffee. He doesn't mention that the FDA designated Fast Track Drug Product Development program and Orphan Drug status for ADVEXIN® in head and neck cancer. That and a token will get you on the subway. He doesn't mention any other INGN's products. So? The article was about Advexin. He apparently works for The Street.com and I don't know if he is another clown like J.Cramer, but I just don't pay any attention to them. Perhaps you ought to.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next